טוען...
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be 25-30% of the population, and is the most common cause of elevated liver enzymes in Korea. NAFLD is a “hot potato” for pharmaceutical companies. Many clinical trials are underway to develop a first-in-class drug to treat...
שמור ב:
| הוצא לאור ב: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Association for the Study of the Liver
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066376/ https://ncbi.nlm.nih.gov/pubmed/27729634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0049 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|